A NEWTOWN-based manufacturer which aids in cancer diagnostics has secured an agreement with a US-based medical company to become its exclusive distributor in the UK.
CellPath, a manufacturer and worldwide supplier of products, consumables, and services related to cancer diagnostics, has signed the agreement with Biocare Medical LLC.
Biocare is a major US innovator, becoming the market leader in the development of simultaneous multiplex immunohistochemistry tests that provide increased confidence at critical diagnostic decision points, positively impacting patient therapy while accelerating turnaround time.
The agreement will take effect from June 1 and should bring significant growth and job expansion to CellPath.